European committee approves the world’s first life-saving gene therapy for children suffering from threatening disease called ADA Severe Combined Immune Deficiency (ADA-SCID).
Strimvelis, a gene therapy developed by an Italian scientist along with Pharmaceutical company GlaxoSmithKline can be used to save children from genetic disorders.
Gene therapy isn’t new and has been around for 25 years but it doesn’t mean to treat all kinds of genetic disorder mostly to children. The drug still needs to overcome obstacles since it’s in its early stage of development. Delivering the treatment is very complex because the bone marrow needs to be extracted from the patient, injected with new genes and put it back in the body.
But who knows, with thorough medical researching and practice may give us hope in determining on how we can live with those new breakthroughs especially in medical development.